Position in AZN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$361,247,147
New position
Shares Held
1,905,111
first reported quarter
Ownership
0.123%
of shares outstanding
% of Portfolio
3.96%
of 13F equity value
Holder Rank
#1
of 116 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 37.72478349030581.ToString("F0")%
Shared 0.ToString("F0")%
None 62.27521650969419.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. AZN ranks #1 (35.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
1,905,111 | $361,247,147 | |
| 2 | ABBV |
AbbVie Inc.
|
680,730 | $171,298,897 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,169,722 | $150,309,277 | |
| 4 | JNJ |
Johnson & Johnson
|
443,703 | $112,687,250 | |
| 5 | LLY |
ELI LILLY & Co
|
81,026 | $97,185,023 | |
| 6 | BIIB |
Biogen Inc.
|
241,101 | $52,092,282 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
635,252 | $36,603,220 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
192,146 | $24,275,725 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $361,247,147 | 1,905,111 | Shares | Sole | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||